David Santamaría

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 2

Top Topics

Patient Reported

Epidermal Growth Factor Receptor

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Nature communications

Institut Européen de Chimie et Biologie

Universidad Autonoma de Madrid Facultad de Ciencias (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institut Européen de Chimie et Biologie Aug 01 2016

France

Group leader

Centro Nacional de Investigaciones Oncológicas Jan 01 2003 - Jul 31 2016

Spain

Staff scientist :: Molecular Oncology

Education History

Universidad Autonoma de Madrid Facultad de Ciencias - Feb 25 1999

Spain

PHD

Publications

Marie-Julie Nokin, Alessia Mira, Enrico Patrucco, Biagio Ricciuti, Sophie Cousin, Isabelle Soubeyran, Sonia San José, Serena Peirone, Livia Caizzi, Sandra Vietti Michelina, Aurelien Bourdon, Xinan Wang, Daniel Alvarez-Villanueva, Maria Martinez-Iniesta, August Vidal Bel, Telmo Rodrigues, María Carmen García-Macías, Mark M Awad, Ernest Nadal, Alberto Villanueva, Antoine Italiano, Matteo Cereda, David Santamaría, Chiara Ambrogio
RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade. Nature communications 15 (1) (2024)
Laura Esteban-Burgos, Haiyun Wang, Patricia Nieto, Jie Zheng, Carmen Blanco-Aparicio, Carmen Varela, Gonzalo Gómez-López, Fernando Fernández-García, Manuel Sanclemente, Carmen Guerra, Matthias Drosten, Javier Galán, Eduardo Caleiras, Jorge L Martínez-Torrecuadrada, Lluis Fajas, Sheng-Bin Peng, David Santamaría, Monica Musteanu, Mariano Barbacid
Tumor regression and resistance mechanisms upon CDK4 and RAF1 inactivation in KRAS/P53 mutant lung adenocarcinomas. Proceedings of the National Academy of Sciences of the United States of America 117 (39) (2020)